BMO
DGX icon

Beck Mack & Oliver’s Quest Diagnostics DGX Stock Holding History

Beck Mack & Oliver’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,494
Closed -$205K – 375
2014
Q2 		$205K Hold
3,494
– – ﹤0.01% 347
2014
Q1 		$202K Buy
+3,494
New +$187K ﹤0.01% 336
2013
Q4 		– Sell
-3,494
Closed -$216K – 370
2013
Q3 		$216K Hold
3,494
– – 0.01% 324
2013
Q2 		$212K Buy
+3,494
New +$208K 0.01% 326

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Beck Mack & Oliver's DGX Position: Q3 2014 in Review

Beck Mack & Oliver sold out of Quest Diagnostics (DGX) in Q3 2014, closing a stake of 3,494 shares — an estimated $205K sold.

Beck Mack & Oliver first reported a position in DGX in Q2 2013 and held it in 4 quarters. The position peaked at $216K in Q3 2013. 485 funds tracked by Wall St. Rank hold DGX as of Q3 2014.

  • Beck Mack & Oliver reported no remaining Quest Diagnostics position as of Q3 2014 after selling out during the quarter.
  • Beck Mack & Oliver sold 3,494 Quest Diagnostics shares in Q3 2014, an estimated $205K.
  • Beck Mack & Oliver first reported a position in Quest Diagnostics in Q2 2013 and held it in 4 quarters.
  • Beck Mack & Oliver's Quest Diagnostics position peaked at $216K in Q3 2013.
  • 485 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2014.

Based on Beck Mack & Oliver's 13F filing for Q3 2014, filed 29 Oct 2014.